
Regulatory Roundup: FDA and FTC Issue Joint Warning Letter on H1N1 Products
The two agencies issued a joint Warning Letter to the owners of a website selling unapproved products intended to treat the swine flu virus.
The US Food and Drug Administration and Federal Trade Commission issued a joint
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





